Oaktree Acquisition Corp. III Life Sciences (OACC) Accounts Payables (2024 - 2026)

Oaktree Acquisition Corp. III Life Sciences filings provide 3 years of Accounts Payables readings, the most recent being $751463.0 for Q1 2026.

  • Quarterly Accounts Payables rose 89.91% to $751463.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $751463.0 through Mar 2026, up 89.91% year-over-year, with the annual reading at $501968.0 for FY2025, 6.26% down from the prior year.
  • Accounts Payables hit $751463.0 in Q1 2026 for Oaktree Acquisition Corp. III Life Sciences, up from $501968.0 in the prior quarter.
  • Across five years, Accounts Payables topped out at $751463.0 in Q1 2026 and bottomed at $381554.0 in Q2 2025.
  • Average Accounts Payables over 3 years is $496715.5, with a median of $458037.5 recorded in 2025.
  • The largest annual shift saw Accounts Payables decreased 6.26% in 2025 before it soared 89.91% in 2026.
  • Oaktree Acquisition Corp. III Life Sciences' Accounts Payables stood at $535515.0 in 2024, then decreased by 6.26% to $501968.0 in 2025, then skyrocketed by 49.7% to $751463.0 in 2026.
  • Per Business Quant, the three most recent readings for OACC's Accounts Payables are $751463.0 (Q1 2026), $501968.0 (Q4 2025), and $414107.0 (Q3 2025).